A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades (Q38987330)

8 September 2017

title

A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades (English)

1 reference

8 September 2017

Ilhame Ameqrane

1

1 reference

8 September 2017

Nicolas Wattiez

series ordinal

2

1 reference

8 September 2017

Pierre Pouget

series ordinal

3

1 reference

8 September 2017

Marcus Missal

series ordinal

4

1 reference

8 September 2017

publication date

9 July 2015

1 reference

8 September 2017

1 reference

8 September 2017

volume

232

1 reference

8 September 2017

issue

19

1 reference

8 September 2017

page(s)

3563-3572

1 reference

The NMDA antagonist model for schizophrenia: promise and pitfalls

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Implicit and explicit timing in oculomotor control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

The neurobiology of thought: the groundbreaking discoveries of Patricia Goldman-Rakic 1937-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Anticipatory movement timing using prediction and external cues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

What makes us tick? Functional and neural mechanisms of interval timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Temporal processing dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Timing dysfunctions in schizophrenia span from millisecond to several-second durations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Ketamine-induced distractibility: An oculomotor study in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

From prediction error to psychosis: ketamine as a pharmacological model of delusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Getting the timing right: experimental protocols for investigating time with functional neuroimaging and psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Ketamine perturbs perception of the flow of time in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Effects of interval duration on temporal processing in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

How do primates anticipate uncertain future events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Functions of delay-period activity in the prefrontal cortex and mnemonic scotomas revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Cellular basis of working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Smooth pursuit eye movements and neuropsychological impairments in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Smooth pursuit ocular motor dysfunction in schizophrenia: evidence for a major gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

N-methyl-D-aspartate receptors and information processing: human choice reaction time under a subanaesthetic dose of ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Timing and velocity randomization similarly affect anticipatory pursuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

A representation of the hazard rate of elapsed time in macaque area LIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Effects of subanesthetic doses of ketamine on sensorimotor information processing in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Psychological effects of ketamine in healthy volunteers. Phenomenological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Effects of pharmacologically induced changes in NMDA receptor activity on human timing and sensorimotor performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Pharmacological treatment effects on eye movement control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Climbing neuronal activity as an event-based cortical representation of time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

The effects of ketamine and risperidone on eye movement control in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Beneficial effects of the NMDA antagonist ketamine on decision processes in visual search.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

NMDA antagonist ketamine reduces task selectivity in macaque dorsolateral prefrontal neurons and impairs performance of randomly interleaved prosaccades and antisaccades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

N-methyl-d-aspartate receptor antagonist ketamine impairs action-monitoring activity in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Frontal non-invasive neurostimulation modulates antisaccade preparation in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Ketamine effects on eye movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-015-4005-Z

Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study

21 January 2018

1 reference

12 December 2020

The time sense; estimation of one second durations by schizophrenic patients

1 reference

12 December 2020

NMDA receptors are involved in temporal integration in the oculomotor system of the cat

1 reference

12 December 2020

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

1 reference

12 December 2020

Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors

1 reference

12 December 2020

A glutamatergic deficiency model of schizophrenia

1 reference

12 December 2020

10.1007/S00213-015-4005-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1036163732

0 references

1 reference